GLP-1 Drugs Transform More Than Waistlines as Usage Doubles

GLP-1 drugs are revolutionizing more than just waistlines, with nationwide usage doubling rapidly. These medications mimic the gut hormone glucagon-like peptide to signal fullness to the brain and slow gut motility. However, they often trigger GI side effects like nausea and vomiting, especially during dose changes.

How GLP-1 Drugs Work Beyond Weight Loss

GLP-1 drugs mimic a natural gut hormone called glucagon-like peptide (GLP). After meals, the stomach stretches and releases GLP, signaling the brain to stop eating.

"With GLP medications, they are the same molecules, stable over time," explained Khraishah. "So they kind of work on the brain to tell the brain, hey, you are full, but also work on the gut to slow down the gut motility."

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store

Get it onGoogle Play

Common Gastrointestinal Side Effects

These mechanisms can lead to GI intolerance, a major issue for patients. Symptoms include nausea, vomiting, and diarrhea.

"The most common side effects of those medications are gut-related symptoms, and that goes back to how those medications work," Khraishah said. These effects are most frequent when starting treatment or adjusting doses, stemming from delayed gastric emptying in the GI tract.

Source Information

Originally published by WKYC 3 Cleveland.Read the original article →

Keep exploring

Same topic: GLP-1

All GLP-1 articles →

Health & Wellness

What's the Deal with Peptides? The Hyped Market Under FDA Review

An in-depth look at the FDA's review of unregulated peptide therapy, the safety concerns raised by experts, and the conflict between industry demand and clinical evidence.

8 min read

Health & Wellness

Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program

Learn how the new Medicare GLP-1 Bridge program works, which drugs are covered, and why major pharmaceutical companies are leading the awareness push for the $50 copay initiative.

8 min read

Medical Research

Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials

Eli Lilly's investigational drug, retatrutide, has shown promising results in clinical trials, offering substantial weight loss and significant improvements in cardiovascular health and type 2 diabetes management.

7 min read

More in GLP-1 Medications

GLP-1 Medications

Understanding GLP-1 Drugs for Weight Loss & Diabetes

GLP-1 drugs mimic natural hormones to reduce hunger, slow digestion, and control blood sugar, aiding weight loss and type 2 diabetes. In Malaysia, over 54% of adults are overweight or obese, prompting Health Ministry rollout for vulnerable groups in 2026. Understand benefits, risks, and safe use guidelines.

3 min read

GLP-1 Medications

Prof Urges Caution on Funding Wegovy Rollout

Prof Jim Mann cautions against broad funding for Wegovy, urging focus on high-risk patients like those with heart disease or diabetes. He emphasizes integrating GLP-1 medications into a national obesity strategy with mandatory nutritional support to prevent weight regain. Early data highlights side effect risks and the need for dietary counseling.

2 min read

GLP-1 Medications

Tom Brady's GLP-1 Role: Chief Wellness Officer at eMed

Retired NFL star Tom Brady has taken on the role of Chief Wellness Officer at eMed, a digital health company specializing in GLP-1 medications such as Wegovy and Zepbound. These popular weight-loss drugs offer game-changing results when paired with clinical guidance. Brady's move highlights the growing intersection of sports fame and evidence-based weight management.

2 min read